Sana Biotechnology Inc (NASDAQ: SANA) on Monday, plunged -0.30% from the previous trading day, before settling in for the closing price of $3.38. Within the past 52 weeks, SANA’s price has moved between $1.52 and $12.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 17.68%. With a float of $122.70 million, this company’s outstanding shares have now reached $223.11 million.
The firm has a total of 328 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Sana Biotechnology Inc (SANA) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Sana Biotechnology Inc is 45.04%, while institutional ownership is 53.36%. The most recent insider transaction that took place on Jan 16 ’25, was worth 289,500. Before that another transaction happened on Jan 08 ’25, when Company’s See Remark 1 sold 290,912 for $6.49, making the entire transaction worth $1,887,320. This insider now owns 4,541,511 shares in total.
Sana Biotechnology Inc (SANA) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 17.68% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 17.56% during the next five years compared to -83.13% drop over the previous five years of trading.
Sana Biotechnology Inc (NASDAQ: SANA) Trading Performance Indicators
Sana Biotechnology Inc (SANA) is currently performing well based on its current performance indicators. A quick ratio of 4.47 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.41, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -0.87 in one year’s time.
Technical Analysis of Sana Biotechnology Inc (SANA)
Analysing the last 5-days average volume posted by the [Sana Biotechnology Inc, SANA], we can find that recorded value of 7.82 million was lower than the volume posted last year of 19.76 million. As of the previous 9 days, the stock’s Stochastic %D was 41.63%. Additionally, its Average True Range was 0.59.
During the past 100 days, Sana Biotechnology Inc’s (SANA) raw stochastic average was set at 32.01%, which indicates a significant increase from 30.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 421.93% in the past 14 days, which was higher than the 180.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.49, while its 200-day Moving Average is $5.07. Now, the first resistance to watch is $3.59. This is followed by the second major resistance level at $3.81. The third major resistance level sits at $4.02. If the price goes on to break the first support level at $3.15, it is likely to go to the next support level at $2.94. Now, if the price goes above the second support level, the third support stands at $2.72.
Sana Biotechnology Inc (NASDAQ: SANA) Key Stats
Market capitalization of the company is 752.42 million based on 223,269K outstanding shares. Right now, sales total 0 K and income totals -283,260 K. The company made 0 K in profit during its latest quarter, and -59,920 K in sales during its previous quarter.
